Australia markets open in 6 hours 13 minutes

Catalyst Biosciences, Inc. (CBIO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.4894-0.0301 (-5.79%)
At close: 04:00PM EDT
0.4800 -0.01 (-1.92%)
After hours: 07:05PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
5,533
7,338
20,948
0
6
Cost of revenue
5,559
7,380
9,163
-
-
Gross profit
-26
-42
11,785
-
-
Operating expenses
Research development
48,061
68,889
52,975
43,859
21,474
Selling general and administrative
17,871
18,963
16,180
13,418
12,354
Total operating expenses
65,932
87,852
69,155
57,277
33,828
Operating income or loss
-65,958
-87,894
-57,370
-57,277
-33,822
Total other income/expenses net
57,389
-78
568
-46
1,538
Income before tax
-8,471
-87,933
-56,241
-55,178
-30,055
Income from continuing operations
-8,471
-87,933
-56,241
-55,178
-30,055
Net income
-8,471
-87,933
-56,241
-55,178
-30,055
Net income available to common shareholders
-8,471
-87,933
-56,241
-55,178
-30,055
Basic EPS
-
-2.87
-2.93
-4.60
-2.68
Diluted EPS
-
-2.87
-2.93
-4.60
-2.68
Basic average shares
-
30,641
19,179
12,004
11,214
Diluted average shares
-
30,641
19,179
12,004
11,214
EBITDA
-
-87,604
-57,232
-57,131
-33,673